Miss Spa Banish Microneedle Spot Treatment

Manufacturer
SALES AND PRODUCT SOLUTIONS | Small Lab Co., Ltd.
Effective date
2021-12-02
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-05-31 23:45:25

Label at a glance#

ProductMiss Spa Banish Microneedle Spot Treatment
Active ingredientSALICYLIC ACID
Label structure9 sections

Dosage and administration

Before applying patches, thoroughly cleanse and dry the affected area Apply patch and press down for 15 seconds, patting the edges of patch to secure and contain the blemish. Leave the patch in place for at least 6 hours or overnight to permit healing To remove, gently peel back and discard Cleanse affected area and repeat application with a fresh blemish patch, if desired.

Label contents#

Full prescribing information#

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Salicylic Acid 0.5%

Purpose

OTC - PURPOSE SECTION

Acne Treatment

Use

INDICATIONS & USAGE SECTION

For the Treatment of Acne
Clears up Acne blemish, blackheads and allows skin to heal

Warnings

WARNINGS SECTION

For external use only.

When using this product

OTC - WHEN USING SECTION

Skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • Before applying patches, thoroughly cleanse and dry the affected area
  • Apply patch and press down for 15 seconds, patting the edges of patch to secure and contain the blemish.
  • Leave the patch in place for at least 6 hours or overnight to permit healing
  • To remove, gently peel back and discard
  • Cleanse affected area and repeat application with a fresh blemish patch, if desired.

Inactive Ingredients

INACTIVE INGREDIENT SECTION

Sodium Hyaluronate, Trehalose, Propanediol, Caprylyl Glycol, Madecassoside, Dipotassium Glycyrrhizate, Ethylhexylglycerin

Miss Spa Banish Microneedle Spot Treatment

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

labellabel

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
1994404salicylic acid 0.5 % Medicated PatchPSN2
1994404salicylic acid 0.005 MG/MG Medicated PatchSCD2
1994404salicylic acid 0.5 % Medicated PatchSY2

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
37520-006-062024-01-30C16284748780-11030e364-f9b8-111a-e063-dadaa90a10e2Miss Spa Banish Microneedle Spot Treatment

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
37520-006-06Miss Spa Banish Microneedle Spot Treatment6 g in 1 PACKETPATCH62

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
37520-006MISS SPA BANISH MICRONEEDLE SPOT TREATMENT (SALICYLIC ACID 0.5%) PATCH [SALES AND PRODUCT SOLUTIONS]2Legacy NDC, 1 package rows20211205_b9c11522-313a-deec-e053-2a95a90aeafc.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 10 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
37520-00637520-006-06

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 8 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
d22ff4d4-e97d-1ebd-e053-2995a90a9a29b9c11522-313a-deec-e053-2a95a90aeafc2021-12-02WarningsExact identifier
spl id: d22ff4d4-e97d-1ebd-e053-2995a90a9a29
spl set id: b9c11522-313a-deec-e053-2a95a90aeafc

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.